JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TALCOTT, R. E.
Right arrow Articles by STOHS, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TALCOTT, R. E.
Right arrow Articles by STOHS, S. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 184, Issue 2, 419-423, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF CYPROTERONE ACETATE PRETREATMENT ON THE IN VITRO METABOLISM OF ANILINE, HEXOBARBITAL AND 3H-DIGITOXIGENIN

R. E. TALCOTT 1 and S. J. STOHS 1

1 Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Nebraska-Lincoln, Lincoln, Nebraska

Cyproterone acetate (50 mg/kg) spironolactone (100 mg/kg) and isotonic saline were administered to separate groups of male and female rats daily for four days. Microsomes then obtained from the cyproterone acetate- and spironolactone-pretreated males and females showed enhanced aniline metabolism compared to corresponding control groups. Both Drugs enhanced the metabolism of hexobarbital by female rat liver microsomes and decreased it in the male. Neither drug seemed to exert these effects through enhanced synthesis on decreased breakdown of cytochrome P-450. A possible relationship between antiandrogenicity and drug metabolism is discussed based on the results of this inivestigation and previous studies on the intracellular mechanism of cyproterone acetate. Both cyproterone acetate and spironolactone increased the total production of polarmetabolites of 3H-digitoxigenin in liver homogenates obtained from rats of either sex. This finding may be germane to investigations concerning the mechanism by which spironolactone protects the rat against chronic digitoxin toxicity.

Submitted on July 17, 1972
Accepted on October 16, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.